MAX
Cronograma AdvisorShares Psychedelics ETF
Horario simple
Horario extendido
Los parámetros principales
| 10 rentabilidad de verano | 0 |
| 3 Rentabilidad de verano | 32.79 |
| 5 Rentabilidad de verano | 0 |
| Beta | 0.14 |
| Comisión | 0.99 |
| Código ISIN | US00768Y3624 |
| Divisa | usd |
| Dueño | AdvisorShares |
| El número de empresas | 13 |
| ISO de país | US |
| La fecha de la base | 2021-09-15 |
| P/BV promedio | 1.75 |
| P/E promedio | 9.37 |
| P/S promedio | 2.15 |
| País | USA |
| Región | Global |
| Rentabilidad anual | 6.6 |
| Rentabilidad divina | 0.31 |
| Sitio web | Sistema |
| Tipo de activo | Equity |
| Top 10 emisores, % | 57.12 |
| Índice | ACTIVE - No Index |
| Cambio en el día | 0% 16.27 $ |
| Cambio en la semana | -6.33% 17.37 $ |
| Cambio en un mes | +2.13% 15.93 $ |
| Cambio en 3 meses | -5.41% 17.2 $ |
| Cambio en seis meses | -18.38% 19.93 $ |
| Cambio para el año | +6.62% 15.26 $ |
| Cambio desde el comienzo del año | -5.65% 17.25 $ |
Pagar la suscripción
Más funcionalidad y datos para el análisis de empresas y cartera está disponible por suscripción
Las principales empresas
| Nombre | Industria | Compartir, % | P/BV | P/S | P/E | EV/Ebitda | Rendimiento de dividendos | |
| #1 |
 COMPASS Pathways plc |
Healthcare | 7.8644 | 1.65 | 0 | -1.91 | -0.69 | 0 |
| #2 |
 Alkermes plc |
Healthcare | 7.7698 | 3.32 | 3.13 | 13.27 | 9.4 | 0 |
| #3 |
 Relmada Therapeutics, Inc. |
Healthcare | 6.6722 | 0.39 | 0 | -0.21 | -0.12 | 0 |
| #4 |
 GH Research PLC |
Healthcare | 6.1726 | 2.04 | 0 | -17.08 | -6.96 | 0 |
| #5 |
 Neurocrine Biosciences |
Healthcare | 5.8272 | 5.49 | 6.03 | 41.64 | 22.57 | 0 |
| #6 |
 Supernus Pharmaceuticals, Inc. |
Healthcare | 5.2346 | 0.0027 | 3.92 | -73.08 | 1941.46 | 0 |
| #7 |
 Alto Neuroscience, Inc. |
Healthcare | 5.0798 | 1.93 | 0 | -1.26 | -2.06 | 0 |
| #8 |
 AbbVie |
Healthcare | 4.6133 | 92.87 | 6.6 | 95.5 | 25.13 | 2.98 |
| #9 |
 Johnson & Johnson |
Healthcare | 4.3527 | 7.21 | 6.24 | 21.94 | 13.34 | 2.79 |
| #10 |
 NRx Pharmaceuticals, Inc. |
Healthcare | 3.5295 | -0.69 | 0 | -1.21 | -1.15 | 0 |
Similar ETF
Otros ETF de la compañía de gestión
| Nombre | Clase | Categoría | Comisión | Rentabilidad anual |
| Equity | 0.83 | 88.68 | ||
| Equity | 0.84 | 1.03 | ||
| Equity | 1.18 | 7 | ||
| Equity | 0.95 | -5.36 | ||
| Equity | 1.28 | 8.64 | ||
| Multi-Asset | 1.71 | 10.5 | ||
| Equity | 1.03 | 65.75 | ||
| Equity | 0.9 | 13.53 | ||
| Equity | 1.1 | 12.22 | ||
| Multi-Asset | 1.51 | 18.37 | ||
| Equity | 0.75 | 9.46 | ||
| Equity | 2.84 | -17.46 | ||
| Equity | 1 | 7.16 | ||
| Equity | 1.01 | -9.01 | ||
| Equity | 0.99 | -2.96 |
Descripción AdvisorShares Psychedelics ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.
Basado en fuentes: porti.ru
